×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
上海药物研究所 [34]
合肥物质科学研究院 [19]
厦门大学 [10]
自动化研究所 [9]
中国医学科学院 北京... [8]
复旦大学上海医学院 [7]
更多...
内容类型
期刊论文 [123]
学位论文 [5]
专利 [4]
会议论文 [2]
发表日期
2022 [12]
2021 [12]
2020 [19]
2019 [22]
2018 [19]
2017 [8]
更多...
学科主题
Cell Biolo... [2]
Cell Biolo... [1]
Chemistry [1]
Oncology [1]
Science & ... [1]
物理化学与绿色催化 [1]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共134条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
PD-L1 Aptamer-Functionalized Metal-Organic Framework Nanoparticles for Robust Photo-Immunotherapy against Cancer with Enhanced Safety
期刊论文
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2022, 页码: 9
作者:
Zhang, Jingfang
;
Li, Wenzhe
;
Qi, Yafei
;
Wang, Guorong
;
Li, Lele
收藏
  |  
浏览/下载:10/0
  |  
提交时间:2023/02/22
DNA Nanotechnology
Immunotherapy
Metal-Organic Frameworks
PD-L1 Aptamer
Spherical Nucleic Acids (SNAs)
Analysis of the efficacy and safety of immunotherapy in advanced thymoma patients
期刊论文
CANCER MEDICINE, 2022
作者:
Hao, Yue
;
Lin, Gen
;
Xiang, Jing
;
Wang, Wenxian
;
Xu, Chunwei
收藏
  |  
浏览/下载:15/0
  |  
提交时间:2022/12/23
efficacy
immune-related adverse events
immunotherapy
thymoma
Optimized dose selective HDAC inhibitor tucidinostat overcomes anti-PD-L1 antibody resistance in experimental solid tumors
期刊论文
BMC Medicine, 2022, 卷号: 20, 期号: 1
作者:
Zhang,Pei
;
Du,Yang
;
Bai,Hua
;
Wang,Zhijie
;
Duan,Jianchun
收藏
  |  
浏览/下载:122/0
  |  
提交时间:2022/11/21
Tucidinostat
Tumor microenvironment
PD-L1
CCL5
Solid tumor
Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor
期刊论文
THORACIC CANCER, 2022
作者:
Wang, Wenxian
;
Wang, Qian
;
Xu, Chunwei
;
Li, Ziming
;
Song, Zhengbo
收藏
  |  
浏览/下载:30/0
  |  
提交时间:2022/12/23
checkpoint inhibitor pneumonitis
Chinese experts consensus
immune checkpoint inhibitor-related adverse effects
Treatment outcomes and prognosis of immune checkpoint inhibitors therapy in patients with advanced thymic carcinoma: A multicentre retrospective study
期刊论文
EUROPEAN JOURNAL OF CANCER, 2022, 卷号: 174
作者:
Wang, Wenxian
;
Lin, Gen
;
Guan, Yelan
;
Zhang, Yuxin
;
Xu, Chunwei
收藏
  |  
浏览/下载:18/0
  |  
提交时间:2022/12/23
Thymic carcinoma
Immunotherapy
PD-1
Efficacy
Immune-related adverse events
The Efficacy of PD-1/PD-L1 Inhibitors in Patients with Liver Metastasis of Non-Small Cell Lung Cancer: A Real-World Study
期刊论文
CANCERS, 2022, 卷号: 14
作者:
Xie, Mingying
;
Li, Na
;
Xu, Xiaoling
;
Xu, Yanjun
;
Li, Hui
收藏
  |  
浏览/下载:23/0
  |  
提交时间:2022/12/22
liver metastasis
non-small cell lung cancer
PD-L1
PD-1
PD-L1 inhibitor
CD8+T cell
Treatment outcomes and prognosis of patients with primary and acquired BRAF-mutated non-small cell lung cancer: A multicenter retrospective study
期刊论文
GENES CHROMOSOMES & CANCER, 2022
作者:
Wang, Wenxian
;
Gu, Xiaodong
;
Si, Jinfei
;
Pu, Xingxiang
;
Wang, Liping
收藏
  |  
浏览/下载:31/0
  |  
提交时间:2022/05/16
BRAF mutation
immune checkpoint inhibitors
non-small cell lung cancer
PD-L1
targeted therapy
Correlation of PD-L1 Expression with Clinicopathological and Genomic Features in Chinese Non-Small-Cell Lung Cancer
期刊论文
JOURNAL OF ONCOLOGY, 2022, 卷号: 2022
作者:
Li, Yue
;
Li, Chong
;
Jiang, Ya
;
Han, Xue
;
Liu, Sisi
收藏
  |  
浏览/下载:15/0
  |  
提交时间:2022/12/23
Case Report: Hepatic Sarcoid-Like Reaction Associated With Checkpoint Inhibition in a NSCLC Patient and a Literature Review
期刊论文
FRONTIERS IN ONCOLOGY, 2022, 卷号: 12
作者:
Lin, Yuxin
;
Zhu, Wei
;
Wu, Bingchen
;
Lan, Huiyin
收藏
  |  
浏览/下载:22/0
  |  
提交时间:2022/05/16
Sarcoid-like reaction
immune checkpoint inhibitor
Toripalimab
PD-1
case report
Associations of Clinical and Molecular Characteristics with the Response to Immune Checkpoint Blockade in Advanced Gastric Cancers
期刊论文
JOURNAL OF ONCOLOGY, 2022, 卷号: 2022
作者:
Xu, Xiaoqing
;
Li, Jingjing
;
Gao, Yiding
;
Lv, Wangxia
;
Wei, Qing
收藏
  |  
浏览/下载:23/0
  |  
提交时间:2022/05/16
©版权所有 ©2017 CSpace - Powered by
CSpace